Formulation and evaluation of chitosan microspheres of aceclofenac for colon‐targeted drug delivery

Formulation and evaluation of chitosan microspheres of aceclofenac for colon‐targeted drug delivery S. K. Umadevi R. Thiruganesh S. Suresh K. Bhaskar Reddy Abstract

The objective of this investigation was to develop novel colon specific drug delivery. Aceclofenac, a NSAID, was successfully encapsulated into chitosan microspheres. Various formulations were prepared by varying the ratio of chitosan, span‐85 and stirring speed and the amount of glutaraldehyde. The SEM study showed that microspheres have smooth surfaces. Microspheres were characterised by Fourier transform infrared (FTIR) spectroscopy and differential scanning calorimetry (DSC) to confirm the absence of chemical interactions between drug and polymer and to know the formation of microspheres structure. The microspheres were evaluated for particle size, encapsulation efficiency, drug loading capacity, mucoadhesion studies, stability studies, in vitro and in vivo drug release studies. Particle sizes, as measured by the laser light scattering technique, were of an average size in the range 41–80 µm. The swelling index was in the range 0.37–0.82 and the entrapment efficiency range was 51–75% for all the formulations. The optimised batch ACM 13 released 83.6% at 8 h and 104% at 24 h in SCF containing rat caecal content. Eudragit coated chitosan microspheres prevented the release of the aceclofenac in the physiological environment of the stomach and small intestine and released 95.9±0.34% in the colon. With regard to release kinetics, the data were best fitted with the Higuchi model and showed zero order release with non‐Fickian diffusion mechanism. The in vivo findings suggest that aceclofenac microspheres exhibit a prolonged effect of aceclofenac in rats and produce a significant anti‐inflammatory effect. The findings of the present study conclusively state that chitosan microspheres are promising for colon targeting of aceclofenac to synchronise with chronobiological symptoms of rheumatoid arthritis. Copyright © 2010 John Wiley & Sons, Ltd.
09 15 2010 10 2010 407 427 10.1002/bdd.722 http://onlinelibrary.wiley.com/termsAndConditions#vor 10.1002/bdd.722 https://onlinelibrary.wiley.com/doi/10.1002/bdd.722 https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdd.722 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fbdd.722 10.3109/03639049709148695 10.1016/S0169-409X(97)00071-9 10.1126/science.3526553 10.1111/j.2042-7158.1993.tb07186.x Eur J Biopharm Rubinstein A 291 41 1995 In vitro and in vivo analysis of colon specificity of calcium pectinate formulations 10.1016/0168-3659(95)00112-3 10.1016/S0168-3659(98)00151-5 10.1016/S0378-5173(03)00061-9 10.3109/10611869408996806 10.1023/A:1018995029167 J Pharm Pharmacol Hardy JG 211 37 1989 Drug delivery to the proximal colon STP Pharm Sci Queen MC 95 10 2000 Surface and blood interaction properties of polyethylene oxide modified chitosan microspheres 10.1016/S0378-5173(98)00269-5 10.1016/S0928-0987(99)00087-1 10.1016/S0928-0987(00)00098-1 10.1016/S1461-5347(98)00059-5 10.1021/js970018g Pharmacology Rang AP 229 2001 Novel Drug Delivery Systems Chein YW MousumiK ChoudhuryPK.Preparation and evaluation of chitosan microspheres. Pharmainfo.net: October2005. Int J Pharm Sci Drug Res Roy S 36 1 2009 Effect of method of preparation on chitosan microspheres of mefenamic acid 10.1016/S0168-3659(97)00187-9 10.1016/j.ijpharm.2003.12.026 Acta Pharm Sci Gungor BE 167 49 2007 Preparation and in vitro evaluation of cefadroxil loaded chitosan microspheres 10.4103/0250-474X.22966 10.1002/(SICI)1097-4628(20000613)76:11<1637::AID-APP4>3.0.CO;2-Q 10.1248/cpb.51.620 10.1208/pt0801012 Iran J Pharm Res Mehrgan H 137 3 2005 The release behavior and kinetic evaluation of diltiazem HCl from various hydrophilic and plastic based matrices J Pharm Sci Khatun M 1 3 2004 Controlled release of naproxen sodium from Eudragit RS 100 transdermal film 10.1016/0304-3959(92)90133-V Proc Soc Exp Biol Med Winter CA 111 7 1962 Carrageenin‐induced edema in hind paw of the rat as an assay for anti inflammatory drugs 10.1016/S0378-8741(03)00272-1 10.1080/03639040600608805 10.1211/0022357991776796 10.1016/j.aca.2006.11.080 10.1615/CritRevTherDrugCarrierSyst.v18.i5.10 10.1016/S0168-3659(97)00203-4 10.3109/02652049609026019 10.1016/0168-3659(87)90035-6 10.1016/0378-5173(94)00413-Y 10.1016/S0928-0987(02)00081-7 10.1248/cpb.33.2469 10.3109/02652049609026027 10.1016/j.ijpharm.2003.09.036 10.1056/NEJM198707233170402 10.1016/S0378-5173(98)00303-2 10.1163/156856200743472 10.1016/S0939-6411(01)00205-3 10.1016/j.carbpol.2006.01.013